Innoviva, Inc.
INVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080014
No open-market purchases or sales by Innoviva, Inc. insiders were filed in the last 90 days; 308 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Innoviva, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- +4 vs. Q3 2023
- Shares held
- 72.6M
- +4.26M (+6.2%) vs. Q3 2023
- Total value
- $1.16B
- +$271.8M (+30.5%) vs. Q3 2023
- New holders
- 28
- 67 more added
- Sold out
- 24
- 71 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 308 | $1.69B |
| Q1 2026 | 285 | $1.76B |
| Q4 2025 | 280 | $1.50B |
| Q3 2025 | 263 | $1.38B |
| Q2 2025 | 266 | $1.47B |
| Q1 2025 | 247 | $1.24B |
| Q4 2024 | 236 | $1.24B |
| Q3 2024 | 221 | $1.41B |
| Q2 2024 | 213 | $1.20B |
| Q1 2024 | 216 | $1.11B |
| Q4 2023 | 197 | $1.16B |
| Q3 2023 | 193 | $892.4M |
| Q2 2023 | 198 | $898.1M |
| Q1 2023 | 193 | $789.0M |
| Q4 2022 | 208 | $1.01B |
| Q3 2022 | 213 | $901.8M |
| Q2 2022 | 219 | $1.17B |
| Q1 2022 | 236 | $1.49B |
| Q4 2021 | 218 | $1.23B |
| Q3 2021 | 208 | $1.18B |
| Q2 2021 | 184 | $939.5M |
| Q1 2021 | 177 | $842.1M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Innoviva, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −105,395−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −91,947−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −68,923−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −57,633−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −54,083−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −38,481−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −32,940−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −28,959−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −21,303−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −18,245−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −16,078−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −15,483−100.0% | Sold out |
| Gallacher Capital Management LLC | 0 | $0 | 0.00% | −14,965−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −13,920−100.0% | Sold out |
| Tokio Marine Asset Management Co Ltd | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −10,121−100.0% | Sold out |
| Mutual of America Capital Management LLC | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −4,819−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,224−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −42−100.0% | Sold out |